8-KItem 5.02 · Officer/Director ChangeItem 8.01 · Other Events
BIOGEN INC. (BIIB)

Feb 11, 2026 — Biogen Board Chair Caroline Dorsa announced she will not stand for re‑election at the 2026…

Filed with the SEC on · Summarized by InvestorsBot

Feb 11, 2026 — Biogen Board Chair Caroline Dorsa announced she will not stand for re‑election at the 2026 Annual Meeting of Stockholders. Company says decision is not due to any disagreement with Biogen or the Board. $BIIB ⚖️ #Biogen #CorporateGovernance

The 8‑K does not identify a successor; Dorsa’s departure creates a Board leadership vacancy to be resolved ahead of the 2026 Annual Meeting. Investors should watch for a chair appointment and related governance updates. $BIIB 👀 #Biogen #Leadership

Read the original filing on SEC EDGAR

Get summaries like this in your inbox every morning

Pick up to 20 companies — we read their SEC filings overnight and send you the plain-English version. Free.

Subscribe free

More from BIOGEN INC.

Biogen ($BIIB) announced Chief Legal Officer Susan H.

8-K · March 11, 2026

Biogen ($BIIB) Board elected Dr.

8-K · February 11, 2026

Biogen ($BIIB) filed a Form 8‑K on Feb 6, 2026 furnishing a press release dated Feb 6, 2026 (Exhibit 99.1)…

8-K · February 6, 2026

Biogen ($BIIB) on Feb 6, 2026 issued a press release announcing results of operations & financial…

8-K · February 6, 2026

Biogen expects a ~$222M pre-tax acquired IPR&D/upfront & milestone charge in Q4 2025, cutting GAAP and…

8-K · January 14, 2026